Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Hair Restoration Dermatologists (US)

Council Members in this Study Group: 285

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITYSunil Dhawan, MD

Clinical Assistant Professor of Dermatology
STANFORD UNIVERSITY
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Sunil Dhawan, MD, is a Clinical Assistant Professor of Dermatology at Stanford University. He has expertise in clinical dermatology including acne, rosacea, psoriasis, eczema, skin cancer, actinic keratosis, lasers and cosmetic dermatology, and managed care. Dr. Dhawan also runs the clinical trialdivision...

Brian Lester, MD

Dermatologist
Brian W Lester, MD
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Brian Lester, MD, is a Dermatologist in private practice in Massachusetts. His interests include clinical dermatology, cosmetic dermatology, dermatopathology, and dermatologic pharmaceuticals. He has experience with clinical trials involving a variety of agents used in psoriasis (e.g. retinoids and...

Michele Pauporte, MD, Dermatologist, JUVA SKIN LASER CENTER INCMichele Pauporte, MD

Dermatologist
JUVA SKIN LASER CENTER INC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Michele Pauporte, MD, is a dermatologist at Juva Skin and Laser Center, in New York City. Dr. Pauporte's areas of expertise include cosmetic procedures and the treatment of skin cancers, including Mohs micrographic surgery and reconstructive surgery. She is also extremely experienced in the use oflasers,...

Michael Bain, MD

Plastic and Reconstructive Physician
Michael A Bain, MD
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Michael Bain, MD, MS, is a Plastic and Reconstructive Physician in private practice based in Southern California. He has experience in all areas of plastic and reconstructive surgery including bariatric, breast, cosmetic, and reconstructive surgery. Dr. Bain’s interests are in the ever changing nature...

Robert Koppel

Owner
ROBERT KOPPEL
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Robert Koppel, MD, is a Dermatologist in private practice in Metairie, Louisiana. He also serves as an Assistant Clinical Professor of Dermatology at the Tulane University School of Medicine. Dr. Koppel is knowledgeable of all aspects of medical, surgical, and cosmetic dermatology, with a particular...

Kenneth Edelson

Clinical Instructor
MOUNT SINAI SCHOOL OF MEDICINE OF
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Kenneth Edelson, MD, FAACS, is a Clinical Instructor at Mount Sinai School of Medicine and attending at The Mount Sinai Hospital. He is an NYC Dermatologist in practice for over 25 years and specializes in cosmetic dermatologic surgery and skin cancer. Dr. Edelson uses lasers and IPL's for facial rejuvenation,...

Mark Jewell, MD, Plastic Surgeon , MARK L JEWELL MD PCMark Jewell, MD

Plastic Surgeon
MARK L JEWELL MD PC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Mark Jewell, MD, is a Plastic Surgeon in private practice in Eugene, Oregon. Dr. Jewell is the past President of the American Society for Aesthetic Plastic Surgery (ASAPS), a select group of board-certified plastic surgeons who have attained the highest level of achievement in cosmetic surgical training,...

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Peplin merger with Leo pharma

November 19, 2009

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY

Leo Pharma completes merger pact with Peplin | www.pharmabiz.com

The recent merger of Peplin with Leo pharma is of some significance and will benefit both companies. It would have been difficult for Peplin to fully develop and market their flagship product alone.

Presta Trial shows good results for Enbrel

October 14, 2009

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY

New data from PRESTA trial demonstrate the benefit of Enbrel in patients with psoriasis & psoriatic arthritis | www.pharmabiz.com

This trial showed predicatably good results for Enbrel in patients with psoriasis and psoriatic arthritis. This included improvement in signs and symptoms and quality of life. This will increase sales of Enbrel in the short term. However the two newer agents, Humira and Stelara have better efficacy,...

Peplin could be beneficial.

July 26, 2009

Peplin Initiates its Final Phase 3 Clinical Trial for PEP005 Gel in AK | www.pipelinereview.com

New product that only requires 2 application days over an area.  May be useful.  Typical source for a product like this, coming from a plant extract.  Considering that 5-flourouracil has several variations, but all have predictable reactions that need minimally a few weeks to heal, it is worth looking...

Will the withdrawl of Efalizumab effect the biologic market?

April 15, 2009

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY

Efalizumab withdrawn from US Market | www.medscape.com

This article is important in that the withdrawal of efalizumab by Genentech was appropriate in view of its serious side effect of progressive multifocal leukoencephalopathy (PML). This biologic agent was already declining in usage because of its other side effects, and the presence of other strongcompetitors...

Antioxidant effect

March 11, 2009

Multivitamins: Fact or Fiction | www.usatoday.com

As I ask patients, what is the antioxidant measure we have for the body to show antioxidants work?

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Office Based Private Practice or Clinic
  • Academic Medical Center/Hospital or Clinic

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Owner
  • Physician - Director
  • President
  • Director
  • Partner